|
PEX11B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.075800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.738200E-02 |
| Normal-vs-Stage2 |
4.807000E-01 |
| Normal-vs-Stage3 |
1.292420E-01 |
| Normal-vs-Stage4 |
1.133030E-01 |
| Stage1-vs-Stage2 |
3.447200E-01 |
| Stage1-vs-Stage3 |
9.307800E-01 |
| Stage1-vs-Stage4 |
7.109200E-01 |
| Stage2-vs-Stage3 |
4.785000E-01 |
| Stage2-vs-Stage4 |
3.579200E-01 |
| Stage3-vs-Stage4 |
7.282600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.896400E-02 |
| Normal-vs-AfricanAmerican |
5.350000E-01 |
| Normal-vs-Asian |
7.068000E-02 |
| Caucasian-vs-AfricanAmerican |
5.701400E-01 |
| Caucasian-vs-Asian |
5.701600E-01 |
| AfricanAmerican-vs-Asian |
3.463000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.159420E-01 |
| Normal-vs-Female |
6.098200E-02 |
| Male-vs-Female |
8.805600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.937900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.090000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.572580E-01 |
| Normal-vs-Age(81-100Yrs) |
9.163600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.138450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.950000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.950800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.973200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.438000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.605000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.151000E-01 |
| Classical-VS-Follicular |
2.657600E-01 |
| Classical-VS-Other |
3.820200E-01 |
| Classical-VS-Normal |
1.798760E-01 |
| Tall-VS-Follicular |
7.604800E-01 |
| Tall-VS-Other |
5.577000E-01 |
| Tall-VS-Normal |
2.200000E-01 |
| Follicular-VS-Other |
7.185600E-01 |
| Follicular-VS-Normal |
8.367900E-02 |
| Other-VS-Normal |
2.453400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.063830E-01 |
| Normal-vs-N1 |
4.683400E-03 |
| N0-vs-N1 |
3.022000E-02 |
|
|
